British Journal of Clinical Pharmacology · 2020 · 12 citations · 19 references
This study points to the potential role of AZA in the occurrence of CF. Cardiac evaluation before AZA initiation and regular monitoring of cardiac function during AZA treatment should be performed in patients with a history of cardiovascular disease.
19
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood · 1997 · 4.4K citations · Full text
Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg et al. · The Lancet Oncology · 2009 · 2.6K citations · Full text
Hematological Malignancy, Higher-risk Myelodysplastic Syndromes, Hematology +6
Polychronis Antonitsis, Elizabeth Ioannidou-Papagiannaki, Aikaterini Kaidoglou et al. · Interactive Cardiovascular and Thoracic Surgery · 2007 · 160 citations